What antihypertensive medication is appropriate for a patient who is allergic to lisinopril?

Switch to an Angiotensin Receptor Blocker (ARB)

For a patient with a documented allergy to lisinopril, an angiotensin receptor blocker (ARB) such as valsartan, candesartan, or losartan is the most appropriate alternative antihypertensive medication. 1, 2

Rationale for ARB Selection

ARBs are the established first-line alternative when ACE inhibitors like lisinopril cannot be used due to allergy. Multiple major hypertension guidelines consistently recommend ARBs as the appropriate substitute 3, 4, 5:

• JNC 8, ESH/ESC, and ACC/AHA guidelines all list ARBs alongside ACE inhibitors as first-line agents, with ARBs specifically indicated for ACE inhibitor intolerance 3, 4
• 2013 ACC/AHA STEMI guidelines explicitly state: "For patients intolerant of ACE inhibitors" use ARBs 1
• 2009 ACC/AHA Heart Failure guidelines confirm ARBs are "a reasonable alternative" when ACE inhibitors cannot be used 2

Critical Safety Consideration: Angioedema Risk

If the lisinopril allergy involved angioedema, exercise extreme caution with ARBs. While angioedema is much less frequent with ARBs than ACE inhibitors, cross-reactivity can occur 2, 6:

• The FDA label for lisinopril contraindicates use in patients with "history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor" 6
• There are documented cases of patients developing angioedema with both ACE inhibitors and subsequently with ARBs 2, 7
• If angioedema was the allergic manifestation, consider alternative drug classes entirely (calcium channel blockers or thiazides) rather than risking ARB exposure

Alternative Options if ARB is Contraindicated

If ARBs cannot be used (or if the allergy was angioedema), select from these evidence-based alternatives based on patient characteristics 3, 4, 5:

Calcium Channel Blockers (CCBs):

• Amlodipine or other dihydropyridines
• Particularly appropriate for patients >55 years or Black patients 3
• Proven mortality and morbidity benefits in major trials

Thiazide/Thiazide-like Diuretics:

• Chlorthalidone or hydrochlorothiazide
• Superior for heart failure prevention compared to ACE inhibitors 8
• Recommended as first-line by AHA/ACC/CDC guidelines 3

Beta-blockers:

• If compelling indications exist (post-MI, heart failure with reduced ejection fraction, angina) 1, 5
• Not preferred as initial monotherapy for uncomplicated hypertension

Specific ARB Recommendations

Preferred ARBs with strongest evidence 1, 2, 9:

• Valsartan: 40-80 mg twice daily, titrate to 160 mg twice daily
• Candesartan: 4-8 mg once daily, titrate to 32 mg once daily
• Losartan: 25-50 mg once daily, titrate to 50-100 mg once daily

These three ARBs have the most robust outcome data for cardiovascular and renal protection, similar to ACE inhibitors.

Common Pitfalls to Avoid

1. Do not combine ACE inhibitors with ARBs - this increases adverse events without improving outcomes 2, 4
2. Do not use aliskiren with ARBs in diabetic patients - contraindicated per FDA 6
3. Monitor for the same adverse effects as ACE inhibitors: hyperkalemia, worsening renal function, and hypotension occur at similar rates with ARBs 2, 9
4. If the patient has chronic kidney disease or diabetes, ARBs provide equivalent nephroprotection to ACE inhibitors 9